This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Reply to Letter to the Editor “Once-Daily Venlafaxine XR Compared With Fluoxetine in Outpatients With Depression and Anxiety”

Peter H. Silverstone and Arun Ravindran

Published: November 30, 1999

Article Abstract

Letter to the Editor

Sir: Drs. Judge and Wagner question the conclusion from our study that venlafaxine XR "provides evidence of superiority over fluoxetine." Their main reason for questioning this conclusion is their belief that the statistically significant differences at week 12 between the venlafaxine XR-treated patients and the fluoxetine-treated patients on the Hamilton Rating Scale for Anxiety (HAM-A) are due to "random noise." Their major justification for this position appears to be that there were no previous statistically significant differences between the 2 drugs at other timepoints.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 60

Quick Links: